OBJECTIVE: To determine the clinical and parasitological response to treatment of intestinal microsporidiosis with albendazole. DESIGN: Open prospective study. SETTING: Hospital-based HIV/genito-urinary medicine unit. PATIENTS, PARTICIPANTS: Six consecutive AIDS patients with small intestinal microsporidiosis as the only identified cause of diarrhoea after intensive gastrointestinal investigations. RESULTS: Diarrhoea resolved completely in all patients within 1 week of starting treatment, and body weight stabilized or increased. Four patients who relapsed at 19-31 days after the cessation of treatment responded to a second course of albendazole. Degenerative changes occurred in the parasites after treatment, which had not been seen either in pre-treatment biopsies or, in four patients, following therapy with other drugs. CONCLUSIONS: Albenazole is a useful palliative treatment for microsporidial diarrhoea.
OBJECTIVE: To determine the clinical and parasitological response to treatment of intestinal microsporidiosis with albendazole. DESIGN: Open prospective study. SETTING: Hospital-based HIV/genito-urinary medicine unit. PATIENTS, PARTICIPANTS: Six consecutive AIDSpatients with small intestinal microsporidiosis as the only identified cause of diarrhoea after intensive gastrointestinal investigations. RESULTS:Diarrhoea resolved completely in all patients within 1 week of starting treatment, and body weight stabilized or increased. Four patients who relapsed at 19-31 days after the cessation of treatment responded to a second course of albendazole. Degenerative changes occurred in the parasites after treatment, which had not been seen either in pre-treatment biopsies or, in four patients, following therapy with other drugs. CONCLUSIONS:Albenazole is a useful palliative treatment for microsporidial diarrhoea.
Authors: P Caramello; G Mazzucco; M Romeo; A Ullio; G DeRosa; A Lucchini; B Forno; T Brancale; A Macor; C Preziosi Journal: Infection Date: 1995 Nov-Dec Impact factor: 3.553
Authors: Peter J Didier; Jennifer N Phillips; Dorothy J Kuebler; Mohamed Nasr; Paul J Brindley; Mary E Stovall; Lisa C Bowers; E S Didier Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191
Authors: D Dionisio; L I Manneschi; S Di Lollo; A Orsi; G Sterrantino; M Meli; M Gabbrielli; A Tani; A Papucci; F Leoncini Journal: J Clin Pathol Date: 1997-06 Impact factor: 3.411
Authors: T van Gool; F Snijders; P Reiss; J K Eeftinck Schattenkerk; M A van den Bergh Weerman; J F Bartelsman; J J Bruins; E U Canning; J Dankert Journal: J Clin Pathol Date: 1993-08 Impact factor: 3.411
Authors: Donna E Akiyoshi; Hilary G Morrison; Shi Lei; Xiaochuan Feng; Quanshun Zhang; Nicolas Corradi; Harriet Mayanja; James K Tumwine; Patrick J Keeling; Louis M Weiss; Saul Tzipori Journal: PLoS Pathog Date: 2009-01-09 Impact factor: 6.823